 OMHHE Health Equity Research Webinar Series – Bridging Gaps in Health Equity: A Conversation with Dr. Claudia Baquet
As we continue our celebration and observance of National Black History Month, the FDA Office of Minority Health and Health Equity invites you to view our latest webinar from the Health Equity Research Series. University of Maryland researcher, Dr. Claudia Baquet, and OMHHE Acting Director, Dr. Christine Lee, discuss Dr. Baquet’s ongoing research with Black and African American communities and COVID-19 clinical trials.
FDA Draft Guidance Document: Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
FDA discusses its standardized approach to collecting and reporting race and ethnicity data in submissions, including information from clinical studies and trials for FDA-regulated medical products.
News At FDA
Don’t Overuse Acetaminophen
FDA discusses the health risks of overusing acetaminophen, and the potential dangers of exceeding the daily limit, including liver damage, nausea, abdominal pain, and jaundice, among other potential side effects.
10 Facts About What FDA Does and Does Not Approve
This consumer update offers insights on how FDA works, claims of products being “FDA Approved,” what that means in a societal and public health context, and the implications of false claims and how they impact the importance of FDA’s role.
FDA Roundup, February 13, 2024
Read the FDA at-a-glance summary of news from around the agency.
Voices in Health Equity
FDA Enhances Global Patient and Regulatory Collaborations in Oncology
By: Vaibhav Kumar, M.D., M.S., Division of Oncology 3, Office of Oncologic Disease, and Rea Blakey, Associate Director, Oncology Center of Excellence, External Outreach and Engagement
In recognition of World Cancer Day 2024, the FDA and European Medicines Agency will collaborate to spotlight innovative cancer treatment advances for patients.
Upcoming Events
Collaborating on Culture in the New Era of Smarter Food Safety
February 14, 12:00 p.m. - 1:00 p.m. ET, Virtual
The FDA and Stop Foodborne Illness, a non-profit public health organization, are collaborating on a webinar series that explores food safety culture, one of the core elements in FDA’s New Era of Smarter Food Safety initiative.
Director’s Innovation Speaker Series: Changing Minds & Advancing Lines: Why We Must Keep for Mental Health Equity
February 20, 2 p.m. - 3 p.m. ET, Virtual
Health equity and policy expert Daniel E. Dawes, J.D., explores the link between mental health and systemic health through the lens of equity and discusses how we can learn from and repair past issues to achieve mental health equity moving forward.
Public Workshop: Biomarker-Driven Drug Development for Allergic Diseases and Asthma
February 22, 8 a.m. - 5 p.m. ET, In-Person/Virtual
This public workshop is a forum regarding the development and use of biomarkers of allergenics to treat respiratory and food allergies.
Expanding Generic Drug Access Through International Engagements
February 28, 9 a.m. - 11:30 a.m. ET, Virtual
In this webinar, the FDA will discuss and provide updates on FDA/EMA’s Parallel Scientific Advice Pilot Program for complex generics/hybrid products, and how Americans can have access to safe, effective, and high-quality generic drugs.
FDA's Rare Disease Day 2024
March 1, 9:00 a.m. - 4:30 p.m. ET, Virtual
Registration is open for the FDA’s virtual public meeting for Rare Disease Day. Panels will discuss efforts to address the unique challenges with developing treatments for rare diseases, as well as the FDA’s efforts to promote new medical products for patients with rare diseases.
Opportunities
FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity
The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance minority health and health equity objectives. Areas of interest include: Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical trials, equitable data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and equity of voices by increasing understanding of diverse patient perspectives, preferences, and unmet needs.
All applications are due by 5:00 PM on February 29, 2024.
In Case You Missed It
Tips for Women to Prevent Heart Disease
Heart disease is the leading cause of death for men and women in the U.S. This American Heart Month, know your risk and protect your heart.
Resources For You
OMHHE offers many easy-to-use and culturally-appropriate resources on minority health, health disparities, and related topics. These resources are available to view online, print, or share. Some are available in Spanish and additional languages.
Visit www.fda.gov/HealthEquityResources for more information.
|
